Is taking 1 mg of aspirin (acetylsalicylic acid) daily contraindicated or problematic for a patient undergoing platelet‑rich plasma (PRP) therapy?

Is 1 mg of Aspirin Daily a Problem for PRP Treatment?

Yes, even 1 mg of aspirin daily is problematic for PRP treatment and should be discontinued 3-5 days before the procedure to optimize platelet function and treatment efficacy.

The Core Issue: Aspirin's Irreversible Platelet Inhibition

Aspirin irreversibly inhibits cyclooxygenase-1 (COX-1), blocking thromboxane A2 synthesis and preventing the platelet activation cascade that is essential for PRP's therapeutic mechanism 1. This inhibition persists for the entire 7-10 day lifespan of affected platelets 2. Even at very low doses (your 1 mg is far below the typical 75-100 mg daily dose), aspirin still exerts this irreversible effect on circulating platelets.

Evidence-Based Washout Period

For PRP procedures, discontinue aspirin for 3-5 days before treatment:

• Standard procedures: 3-day washout leads to improvement in platelet function that is often sufficient 1
• High bleeding-risk procedures: 5-day washout is recommended to ensure complete correction of platelet functions in all patients 1

The rationale: After 3 days, approximately 30-40% of platelets are "naïve" (unaffected by aspirin). After 5 days, roughly 50% of platelets have normal function. While complete recovery requires 7-10 days for full platelet turnover 2, a 3-5 day washout provides adequate functional recovery for most therapeutic applications 1.

Impact on PRP Efficacy

Recent laboratory evidence demonstrates that aspirin significantly impairs PRP's therapeutic potential:

• Growth factor release is substantially reduced: Aspirin significantly inhibits arachidonic acid-mediated release of VEGF, PDGF-AB, and TGF-β1 from leukocyte-rich PRP 3
• Even thrombin activation is partially affected: Aspirin partially blocks thrombin-mediated release of PDGF-AB, though VEGF and TGF-β1 release remain intact with thrombin activation 3
• Systematic review confirms: Aspirin causes significant decreases in platelet aggregation and should be suspended before PRP injections 4

Critical Caveats

When Aspirin Cannot Be Stopped

If you're taking aspirin for cardiovascular protection (post-MI, post-stent, stroke prevention), do not stop aspirin without cardiology consultation. The thrombotic risk may far outweigh any benefit from optimized PRP treatment 2. In such cases:

• Consider proceeding with PRP while on aspirin, accepting reduced efficacy
• One case report showed successful PRP treatment despite chronic antiplatelet therapy 5
• Recent animal data suggests aspirin may not completely abolish PRP benefits 6

Dose Considerations

Your 1 mg dose is unusually low (typical cardioprotective dosing is 75-100 mg daily). However, aspirin's effect is not strictly dose-dependent for platelet inhibition because it acts irreversibly 1. Even low doses will inhibit COX-1 in platelets that are exposed to the drug. The bleeding risk may be lower with 1 mg versus 300 mg, but the platelet dysfunction relevant to PRP efficacy persists 1.

Faster Recovery Scenarios

Some patients may recover platelet function more quickly due to accelerated platelet turnover:

• Diabetics
• Patients with higher body weight
• Those with thrombocytosis from myeloproliferative disorders 1

However, do not rely on this variability—use the standard 3-5 day washout period.

Practical Algorithm

1. Assess cardiovascular risk: If aspirin is for primary prevention only → safe to discontinue for 3-5 days
2. If aspirin is for secondary prevention (post-MI, post-stent, stroke) → consult cardiology before stopping
3. Standard PRP procedures: Stop aspirin 3 days before injection
4. If concerned about suboptimal response: Stop aspirin 5 days before injection for maximal platelet recovery
5. Resume aspirin: Can restart immediately after PRP injection if needed for cardiovascular protection

Bottom Line

Stop your 1 mg daily aspirin for 3-5 days before PRP treatment unless you have compelling cardiovascular indications that require continuous antiplatelet therapy 1, 3, 4. The irreversible nature of aspirin's platelet inhibition means even very low doses compromise the growth factor release mechanism that underlies PRP's therapeutic effects.